The value of reporting therapeutic ineffectiveness as an adverse drug reaction

Drug Safety

Volumn 23, Issue 2, 2000, Pages 95-99

  Meyboom, Ronald H B ^a   Lindquist, Maire ^a   Flygare, Anna Karin ^a   Biriell, Cecilia ^a   Edwards, I Ralph ^a  

^a UPPSALA MONITORING CENTRE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADVERSE DRUG REACTION; DRUG EFFICACY; DRUG INTERACTION; DRUG METABOLISM; DRUG RESISTANCE; DRUG SURVEILLANCE PROGRAM; DRUG TOLERANCE; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE;

EID: 0033852714     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200023020-00001     Document Type: Review

References (8)

1. 1. Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf 1994; 10: 93-102
2. 2. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996; 16: 701-7
3. 3. The Uppsala Monitoring Centre. Safety monitoring of medicinal products - guidelines for the setting up and running of a pharmacovigilance centre. Uppsala: The Uppsala Monitoring Centre, 2000
4. 4. Walley T. Drugs, money and society. Br J Clin Pharmacol 1995; 39: 343-5
5. 5. Kimura K. The WHO data base on counterfeit pharmaceuticals. Geneva: World Health Organization, 1998
6. 6. O'Brien CP. Drug addiction and drug abuse. In: Hardman JG, Limbird LE, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York (NY): McGraw-Hill, 1996: 557-77
7. 7. The Uppsala Monitoring Centre. Adverse reaction terminology. Uppsala: The Uppsala Monitoring Centre, 1998
8. 8. The Uppsala Monitoring Centre. Guide to participating countries. Uppsala: The Uppsala Monitoring Centre, 1998: 9